■ Demo— not a validated GxP system — synthetic data

Affinis

Compound registry

KIN-07 · EGFR mutant-selective — structures, computed properties and batches

Register a compound…
Series
Status
Registered compounds, with their computed properties and mutant-EGFR potency
StructureCompoundSeriesR-groupsFormulaMWcLogPTPSA (Ų)BatchespIC50 mutStatus
NHNNNOClAFN-003850BR1 CN · R6 OEt · R7 ClC17H13ClN4O324.84.3070.80—designed
NHNNNOOHAFN-003851BR1 CN · R6 OEt · R7 OHC17H14N4O2306.33.3591.10—designed
NHNNNOOAFN-003852BR1 CN · R6 OCH2CH2OMe · R7 HC18H16N4O2320.43.2780.10—designed
NHNNNOOOAFN-003853BR1 CN · R6 OCH2CH2OMe · R7 OMeC19H18N4O3350.43.2889.30—designed
NHNNNOOOAFN-003854BR1 CN · R6 OCH2CH2OMe · R7 OEtC20H20N4O3364.43.6789.30—designed
NHNNNOOOOAFN-003855BR1 CN · R6 OCH2CH2OMe · R7 OCH2CH2OMeC21H22N4O4394.43.3098.50—designed
NHNNNOOFAFN-003856BR1 CN · R6 OCH2CH2OMe · R7 FC18H15FN4O2338.33.4180.10—designed
NHNNNOOONOAFN-003857BR1 CN · R6 OCH2CH2OMe · R7 O(CH2)2-morpholinoC24H27N5O4449.52.98101.80—designed
NHNNNOOClAFN-003858BR1 CN · R6 OCH2CH2OMe · R7 ClC18H15ClN4O2354.83.9280.10—designed
NHNNNOOOHAFN-003859BR1 CN · R6 OCH2CH2OMe · R7 OHC18H16N4O3336.42.98100.30—designed
NHNNNONOAFN-003860BR1 CN · R6 O(CH2)3-morpholino · R7 HC22H23N5O2389.53.3583.30—designed
NHNNNONOOAFN-003861BR1 CN · R6 O(CH2)3-morpholino · R7 OMeC23H25N5O3419.53.3592.517.65tested
NHNNNONOOAFN-003862BR1 CN · R6 O(CH2)3-morpholino · R7 OEtC24H27N5O3433.53.7492.50—designed
NHNNNONOOOAFN-003863BR1 CN · R6 O(CH2)3-morpholino · R7 OCH2CH2OMeC25H29N5O4463.53.37101.80—designed
NHNNNONOFAFN-003864BR1 CN · R6 O(CH2)3-morpholino · R7 FC22H22FN5O2407.43.4983.30—designed
NHNNNONOONOAFN-003865BR1 CN · R6 O(CH2)3-morpholino · R7 O(CH2)2-morpholinoC28H34N6O4518.63.06105.00—designed
NHNNNONOClAFN-003866BR1 CN · R6 O(CH2)3-morpholino · R7 ClC22H22ClN5O2423.94.0083.30—designed
NHNNNONOOHAFN-003867BR1 CN · R6 O(CH2)3-morpholino · R7 OHC22H23N5O3405.53.05103.50—designed
NHNNNNHOAFN-003868BR1 CN · R6 acrylamido · R7 HC18H13N5O315.33.3790.717.91tested
NHNNNNHOOAFN-003869BR1 CN · R6 acrylamido · R7 OMeC19H15N5O2345.43.3899.90—designed
NHNNNNHOOAFN-003870BR1 CN · R6 acrylamido · R7 OEtC20H17N5O2359.43.7799.90—designed
NHNNNNHOOOAFN-003871BR1 CN · R6 acrylamido · R7 OCH2CH2OMeC21H19N5O3389.43.39109.20—designed
NHNNNNHOFAFN-003872BR1 CN · R6 acrylamido · R7 FC18H12FN5O333.33.5190.70—designed
NHNNNNHOONOAFN-003873BR1 CN · R6 acrylamido · R7 O(CH2)2-morpholinoC24H24N6O3444.53.08112.418.54tested
NHNNNNHOClAFN-003874BR1 CN · R6 acrylamido · R7 ClC18H12ClN5O349.84.0290.70—designed
NHNNNNHOOHAFN-003875BR1 CN · R6 acrylamido · R7 OHC18H13N5O2331.33.08110.918.17tested
NHNNNAFN-003876BR1 NMe2 · R6 H · R7 HC16H16N4264.33.4441.10—designed
NHNNNOAFN-003877BR1 NMe2 · R6 H · R7 OMeC17H18N4O294.43.4550.30—designed
NHNNNOAFN-003878BR1 NMe2 · R6 H · R7 OEtC18H20N4O308.43.8450.30—designed
NHNNNOOAFN-003879BR1 NMe2 · R6 H · R7 OCH2CH2OMeC19H22N4O2338.43.4659.50—designed
NHNNNFAFN-003880BR1 NMe2 · R6 H · R7 FC16H15FN4282.33.5841.10—designed
NHNNNONOAFN-003881BR1 NMe2 · R6 H · R7 O(CH2)2-morpholinoC22H27N5O2393.53.1562.80—designed
NHNNNClAFN-003882BR1 NMe2 · R6 H · R7 ClC16H15ClN4298.84.0941.10—designed
NHNNNOHAFN-003883BR1 NMe2 · R6 H · R7 OHC16H16N4O280.33.1561.30—designed
NHNNNOAFN-003884BR1 NMe2 · R6 OMe · R7 HC17H18N4O294.43.4550.30—designed
NHNNNOOAFN-003885BR1 NMe2 · R6 OMe · R7 OMeC18H20N4O2324.43.4659.50—designed
NHNNNOOAFN-003886BR1 NMe2 · R6 OMe · R7 OEtC19H22N4O2338.43.8559.50—designed
NHNNNOOOAFN-003887BR1 NMe2 · R6 OMe · R7 OCH2CH2OMeC20H24N4O3368.43.4768.70—designed
NHNNNOFAFN-003888BR1 NMe2 · R6 OMe · R7 FC17H17FN4O312.43.5950.30—designed
NHNNNOONOAFN-003889BR1 NMe2 · R6 OMe · R7 O(CH2)2-morpholinoC23H29N5O3423.53.1672.00—designed
NHNNNOClAFN-003890BR1 NMe2 · R6 OMe · R7 ClC17H17ClN4O328.84.1050.30—designed
NHNNNOOHAFN-003891BR1 NMe2 · R6 OMe · R7 OHC17H18N4O2310.43.1570.50—designed
NHNNNOAFN-003892BR1 NMe2 · R6 OEt · R7 HC18H20N4O308.43.8450.30—designed
NHNNNOOAFN-003893BR1 NMe2 · R6 OEt · R7 OMeC19H22N4O2338.43.8559.50—designed
NHNNNOOAFN-003894BR1 NMe2 · R6 OEt · R7 OEtC20H24N4O2352.44.2459.50—designed
NHNNNOOOAFN-003895BR1 NMe2 · R6 OEt · R7 OCH2CH2OMeC21H26N4O3382.53.8668.70—designed
NHNNNOFAFN-003896BR1 NMe2 · R6 OEt · R7 FC18H19FN4O326.43.9850.30—designed
NHNNNOONOAFN-003897BR1 NMe2 · R6 OEt · R7 O(CH2)2-morpholinoC24H31N5O3437.53.5572.00—designed
NHNNNOClAFN-003898BR1 NMe2 · R6 OEt · R7 ClC18H19ClN4O342.84.4950.30—designed
NHNNNOOHAFN-003899BR1 NMe2 · R6 OEt · R7 OHC18H20N4O2324.43.5470.51—tested

Properties calculated with RDKit offline, not at runtimeSubstructure: our own screen fingerprint, then VF2 matching — no RDKit at runtimepIC50 mut = mean of approved fits on ASY-EGFR-TM-03